Beijing-based ZGC Shuimu Medical Technology Services Group, China’s first private third-party medical device testing institution, has reportedly raised RMB 100 million (USD 18.8 million) in a Series A+ financing round. The round was led by Yijing Capital and Green Pine Capital Partners. This follows the company’s Series A financing round closed in August of last year.
Company Profile
Founded in 2017, Shuimu Medtech has established itself as a one-stop service platform covering the entire industry chain nationwide. The company integrates engineering R&D, inspection and testing, clinical trials, and registration services, including R&D and production of standard IVD products and quality control products.
Service Offerings
Shuimu Medtech operates medical device reliability, electrical safety, electromagnetic compatibility, software testing, packaging testing, and IVD inspection and testing laboratories. Its business model focuses on mechatronic compliance, reliability, ease of use, and efficacy improvement analysis for large medical equipment such as protons, heavy ions, surgical robots, and radiotherapy devices.
Client Base
The company has over 350 clients, with projects primarily related to high-end medical devices and IVD products.-Fineline Info & Tech
